Brain Imaging and Brain Chemistry in Major Depression and Bipolar Disorder
 (J. John Mann, MD; IRB # 3924R, 3752, 4086, and 3986R)

This study uses brain imaging technology (PET scans) to visualize and research brain biochemistry, as well as a lumbar puncture procedure (spinal tap) to research biological elements identified with depression and suicidal behavior. In exchange for study participation, patients receive no-cost inpatient or outpatient treatment between two to six months, depending on their clinical needs.

 Eligibility:

bullet

Ages 18 to 75

bullet

Meets criteria for Major Depressive Disorder or any type of Bipolar Disorder

bullet

Currently depressed

Benefits to participant:

bullet

Free, thorough clinical evaluation by doctoral-level psychologist and/or psychiatrist

bullet

No-cost inpatient or outpatient treatment

 For more information about participating, contact:

Maria Oquendo, MD or Batsheva Halberstam, BA

Phone: 212-543-5834

E-mail: sadiac@neuron.cpmc.columbia.edu

[HOME]   [GENERAL INFORMATION]   [CURRENT STUDIES]